News

Targeted Oncology8m
FDA Review Underway for Oral Venetoclax, Acalabrutinib Combo in Untreated CLL
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.
Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival
Medical-technology companies are helping revive initial public offerings in the life-sciences sector in the US after a tough ...
Biotech Underdogs Line Up for Pivotal Shots at Game-Changing Cancer Treatments
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, B.C., July 29, 2025 /PRNewswire/ -- Equity Insider News Commentary – ...
Sarepta Therapeutics, Inc. (SRPT): “You Don’t Court Homicide,” Says Jim Cramer
We recently published 11 Stocks That Jim Cramer Recently Talked About. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is one of the ...
Equity Insider: AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks
Equity Insider News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 29, 2025 /PRNewswire/ -- Equity Insider News Commentary - There's a lot of big ...